RxNorm

RxNorm assigns a unique identifier, the RxCUI, to every clinical drug concept. This normalization process links equivalent terms from different source vocabularies—such as GS, MTHSPL, and VANDF—to a single, unambiguous concept. This eliminates the ambiguity caused by multiple proprietary drug codes, ensuring that a specific active ingredient, dose form, and strength combination is represented consistently across systems.

RxNorm organizes drug knowledge into a strict hierarchy of Term Types (TTY) to represent different levels of granularity. Key levels include:

• Ingredient (IN): The active chemical substance (e.g., Atorvastatin).
• Clinical Drug Component (SCDC): Ingredient + Strength.
• Clinical Drug Form (SCDF): Ingredient + Dose Form.
• Clinical Drug (SCD): Ingredient + Strength + Dose Form.
• Branded Drug (SBD): A specific marketed product. This structure allows systems to query at the precise level of abstraction needed for clinical decision support.

RxNorm acts as a central translation hub, enabling semantic interoperation between pharmacy knowledge bases, electronic health records (EHRs), and billing systems. It maps its normalized concepts to external code systems like NDC for dispensing, UNII for active ingredients, and SNOMED CT for clinical documentation. This allows a drug allergy recorded in SNOMED CT to trigger an alert when a corresponding NDC-coded medication is ordered, closing a critical patient safety loop.

A subset of RxNorm known as the Current Prescribable Content (CPC) is curated to include only drugs that are actively prescribable in the United States. This filtered list excludes obsolete, discontinued, or non-clinical forms like bulk powders. The CPC is a practical resource for building e-prescribing interfaces and medication reconciliation tools, ensuring clinicians select from a clean, relevant list of currently available therapeutic options.

RxNorm is updated monthly by the U.S. National Library of Medicine (NLM) . It maintains a robust historical mechanism where retired or obsolete RxCUIs are not deleted but marked as inactive and remapped to their current successors. This versioning is critical for longitudinal clinical research and quality reporting, allowing analysts to accurately reconstruct a patient's medication list as it was documented at a specific point in time, despite ongoing terminology changes.